Literature DB >> 8565050

Block by 5-hydroxytryptamine of neuronal acetylcholine receptor channels expressed in Xenopus oocytes.

K Nakazawa1, T Akiyama, K Inoue.   

Abstract

1. Effects of 5-hydroxytryptamine (5-HT) on neuronal nicotinic acetylcholine (ACh) receptor channels were investigated by expressing cloned channel subunits in Xenopus oocytes. 2. When channels were expressed with a combination of alpha 3 and beta 4 subunits, 5-HT (10 to 300 microM) reversibly inhibited an inward current activated by 100 microM ACh in a concentration-dependent manner. The inhibition was also observed when alpha 3 subunit was combined with beta 2 subunit instead of beta 4 subunit, or beta 4 subunit was combined with alpha 2 or alpha 4-1 subunit instead of alpha 3 subunit to express channels. 3. Compounds known to antagonize at 5-HT receptors (LY53857, metoclopramide and propranolol) exhibited an agonistic effect: they inhibited the ACh-activated current. 4. The results suggest that 5-HT inhibits recombinant neuronal nicotinic receptor channels through a binding-site distinct from conventional 5-HT receptors. The binding-site may not be attributed to a unique type of channel subunits.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8565050     DOI: 10.1007/bf02071882

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  10 in total

Review 1.  The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity.

Authors:  R L Papke
Journal:  Prog Neurobiol       Date:  1993-10       Impact factor: 11.685

2.  Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

Authors:  P B Bradley; G Engel; W Feniuk; J R Fozard; P P Humphrey; D N Middlemiss; E J Mylecharane; B P Richardson; P R Saxena
Journal:  Neuropharmacology       Date:  1986-06       Impact factor: 5.250

Review 3.  A proposed new nomenclature for 5-HT receptors.

Authors:  P P Humphrey; P Hartig; D Hoyer
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

4.  Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors.

Authors:  C W Luetje; J Patrick
Journal:  J Neurosci       Date:  1991-03       Impact factor: 6.167

5.  Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol.

Authors:  D N Middlemiss
Journal:  Eur J Pharmacol       Date:  1984-06-01       Impact factor: 4.432

6.  5-hydroxytryptamine inhibits cholinergic transmission through 5-HT1A receptor subtypes in rabbit vesical parasympathetic ganglia.

Authors:  T Nishimura; T Tokimasa; T Akasu
Journal:  Brain Res       Date:  1988-03-01       Impact factor: 3.252

7.  Block by apomorphine of acetylcholine receptor channels expressed in Xenopus oocytes.

Authors:  K Nakazawa; T Akiyama; K Inoue
Journal:  Eur J Pharmacol       Date:  1994-11-15       Impact factor: 4.432

8.  Blockage of nicotinic acetylcholine receptors by 5-hydroxytryptamine.

Authors:  F Grassi; L Polenzani; A M Mileo; C G Caratsch; F Eusebi; R Miledi
Journal:  J Neurosci Res       Date:  1993-04-01       Impact factor: 4.164

9.  5-Hydroxytryptamine decreases the sensitivity of nicotinic acetylcholine receptor in bull-frog sympathetic ganglion cells.

Authors:  T Akasu; K Koketsu
Journal:  J Physiol       Date:  1986-11       Impact factor: 5.182

10.  Serotonin modulates nicotinic responses of adrenal chromaffin cells.

Authors:  S Vijayaraghavan; H A Schmid; K S Mapp
Journal:  J Neurochem       Date:  1993-07       Impact factor: 5.372

  10 in total
  2 in total

1.  N-methyl serotonin analogues from the Bufo bufo toad venom interact efficiently with the α7 nicotinic acetylcholine receptors.

Authors:  E V Kryukova; D S Lebedev; I A Ivanov; D A Ivanov; V G Starkov; V I Tsetlin; Yu N Utkin
Journal:  Dokl Biochem Biophys       Date:  2017-04-19       Impact factor: 0.788

2.  Threonine-for-leucine mutation within domain M2 of the neuronal alpha(7) nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist.

Authors:  E Palma; A M Mileo; F Eusebi; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.